Theravance Biopharma (TBPH) Stock Chart & Stock Price History $11.30 -0.16 (-1.40%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$11.30 0.00 (0.00%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance The Theravance Biopharma (TBPH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 20.60%, with a year-to-date return of 20.09%. In the past month, the stock has increased 6.50%, reflecting recent market activity. As of the latest close, Theravance Biopharma traded at $11.30 with a market cap of $565 million and volume of 179,091 shares. Five years ago, the stock traded at $21.62, representing a 47.73% decrease over that period. At the time, it had a market cap of $1.33 billion and a volume of 386,928 shares. Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.09%1 Month Performance+6.50%3 Month Performance+34.52%Year-To-Date Performance+20.09%1 Year Performance+20.60%5 Year Performance-47.73% TBPH Stock Chart for Saturday, July, 12, 2025 TBPH Chart by TradingView Theravance Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$11.46$11.30-1.40%$11.41$11.25179,091 shs$565 million07/10/2025$11.59$11.46-1.12%$11.59$11.23120,555 shs$573 million07/09/2025$11.22$11.59+3.30%$11.68$11.18148,765 shs$579.51 million07/08/2025$11.31$11.22-0.80%$11.34$11.15165,866 shs$561 million07/07/2025$11.19$11.31+1.12%$11.32$10.95201,566 shs$565.50 million07/04/2025$11.19$11.19$11.25$11.0065,540 shs$559.25 million07/03/2025$11.05$11.19+1.22%$11.25$11.0065,540 shs$559.25 million07/02/2025$10.91$11.05+1.28%$11.17$10.91169,970 shs$552.50 million07/01/2025$11.03$10.91-1.09%$11.12$10.87173,509 shs$545.50 million06/30/2025$11.22$11.03-1.69%$11.37$11.00208,255 shs$551.51 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$10.73$11.22+4.57%$11.44$10.831.36 million shs$561 million06/26/2025$10.58$10.73+1.42%$10.80$10.58118,136 shs$536.50 million06/25/2025$10.67$10.58-0.84%$10.71$10.4694,491 shs$529 million06/24/2025$10.57$10.67+0.95%$10.77$10.55146,181 shs$533.50 million06/23/2025$10.63$10.57-0.56%$10.69$10.44142,685 shs$528.50 million06/20/2025$10.62$10.63+0.09%$10.69$10.56193,858 shs$531.50 million06/19/2025$10.62$10.62$10.72$10.53162,054 shs$531 million06/18/2025$10.60$10.62+0.19%$10.72$10.53162,054 shs$531 million06/17/2025$10.75$10.60-1.40%$11.00$10.42181,277 shs$530.01 million06/16/2025$10.69$10.75+0.56%$10.80$10.65155,522 shs$537.51 million06/13/2025$10.61$10.69+0.75%$10.73$10.46186,967 shs$534.51 million06/12/2025$10.61$10.61$10.70$10.55310,183 shs$530.51 million06/11/2025$10.73$10.61-1.12%$10.78$10.52272,170 shs$530.51 million Related Companies NAMS Stock Price Chart APGE Stock Price Chart RXRX Stock Price Chart DNLI Stock Price Chart VCEL Stock Price Chart AGIO Stock Price Chart CGON Stock Price Chart KNSA Stock Price Chart BEAM Stock Price Chart IDYA Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TBPH Stock Alerts